1. Centers for Disease Control and Prevention, Statistics NCfH. Underlying Cause of Death 1999-2019 on CDC WONDER Online Database, released in 2020. Center for Disease Control and Prevention. Accessed 02/04/2021, 2021. http://wonder.cdc.gov/ucd-icd10.html
2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. Jan 2021;71(1):7-33. doi:10.3322/caac.21654
3. Murphy SL, Xu J, Kochanek KD, Arias E, Tejada-Vera B. Deaths: Final Data for 2018. Natl Vital Stat Rep. Jan 2021;69(13):1-83.
4. Gordis L. Epidemiology. Fifth edition. ed. Elsevier/Saunders; 2014:xv, 392 pages.
5. Lawson A, Banerjee S, Haining RP, Ugarte MaD. Handbook of spatial epidemiology. Chapman & Hall/CRC handbooks of modern statistical methods. CRC Press/Taylor & Francis; 2016:xviii, 684 pages.
6. Krieger N. Place, space, and health: GIS and epidemiology. Epidemiology. Jul 2003;14(4):384-5. doi:10.1097/01.ede.0000071473.69307.8a
7. Cromley EK, McLafferty S. GIS and public health. 2nd ed. The Guilford Press; 2012:xxiv, 503 p.
8. Krieger N. Follow the North Star: Why Space, Place, and Power Matter for Geospatial Approaches to Cancer Control and Health Equity. Cancer Epidemiol Biomarkers Prev. Apr 2017;26(4):476-479. doi:10.1158/1055-9965.EPI-16-1018
9. Prehn AW, West DW. Evaluating local differences in breast cancer incidence rates: a census-based methodology (United States). Cancer Causes Control. Oct 1998;9(5):511-7. doi:10.1023/a:1008809819218
10. Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Publ Health. 1997;18:341-78. doi:10.1146/annurev.publhealth.18.1.341
11. Baade PD, Yu XQ, Smith DP, Dunn J, Chambers SK. Geographic disparities in prostate cancer outcomes--review of international patterns. Asian Pac J Cancer Prev. 2015;16(3):1259-75. doi:10.7314/apjcp.2015.16.3.1259
12. Wan N. Pesticides exposure modeling based on GIS and remote sensing land use data. Appl Geogr. Jan 2015;56:99-106. doi:10.1016/j.apgeog.2014.11.012
13. Hines R, Markossian T, Johnson A, Dong F, Bayakly R. Geographic residency status and census tract socioeconomic status as determinants of colorectal cancer outcomes. Am J Public Health. Mar 2014;104(3):e63-71. doi:10.2105/AJPH.2013.301572
14. Cooper RA, Cooper MA, McGinley EL, Fan X, Rosenthal JT. Poverty, wealth, and health care utilization: a geographic assessment. J Urban Health. Oct 2012;89(5):828-47. doi:10.1007/s11524-012-9689-3
15. Gumpertz ML, Pickle LW, Miller BA, Bell BS. Geographic patterns of advanced breast cancer in Los Angeles: associations with biological and sociodemographic factors (United States). Cancer Causes Control. Apr 2006;17(3):325-39. doi:10.1007/s10552-005-0513-1
16. Graves BA. Integrative literature review: a review of literature related to geographical information systems, healthcare access, and health outcomes. Perspect Health Inf Manag. Jul 29 2008;5:11.
17. Nykiforuk CI, Flaman LM. Geographic information systems (GIS) for Health Promotion and Public Health: a review. Health Promot Pract. Jan 2011;12(1):63-73. doi:10.1177/1524839909334624
18. Aghajani J, Farnia P, Velayati AA. Impact of geographical information system on public health sciences. Biomedical and Biotechnology Research Journal (BBRJ). 2017;1(2):94.
19. Kuo TM, Mobley LR, Anselin L. Geographic disparities in late-stage breast cancer diagnosis in California. Health Place. Jan 2011;17(1):327-34. doi:10.1016/j.healthplace.2010.11.007
20. Meliker JR, Jacquez GM, Goovaerts P, Copeland G, Yassine M. Spatial cluster analysis of early stage breast cancer: a method for public health practice using cancer registry data. Cancer Cause Control. Sep 2009;20(7):1061-1069. doi:10.1007/s10552-009-9312-4
21. Grann V, Troxel AB, Zojwalla N, Hershman D, Glied SA, Jacobson JS. Regional and racial disparities in breast cancer-specific mortality. Soc Sci Med. Jan 2006;62(2):337-47. doi:10.1016/j.socscimed.2005.06.038
22. Sturgeon SR, Schairer C, Gail M, Mcadams M, Brinton LA, Hoover RN. Geographic-Variation in Mortality from Breast-Cancer among White Women in the United-States. J Natl Cancer I. Dec 20 1995;87(24):1846-1853. doi:DOI 10.1093/jnci/87.24.1846
23. Ou JY, Fowler B, Ding Q, et al. A statewide investigation of geographic lung cancer incidence patterns and radon exposure in a low-smoking population. Bmc Cancer. Jan 31 2018;18(1):115. doi:10.1186/s12885-018-4002-9
24. Lin CK, Hsu YT, Christiani DC, Hung HY, Lin RT. Risks and burden of lung cancer incidence for residential petrochemical industrial complexes: A meta-analysis and application. Environ Int. Dec 2018;121(Pt 1):404-414. doi:10.1016/j.envint.2018.09.018
25. Guo YM, Zeng HM, Zheng RS, et al. The association between lung cancer incidence and ambient air pollution in China: A spatiotemporal analysis. Environ Res. Jan 2016;144:60-65. doi:10.1016/j.envres.2015.11.004
26. Farazi PA, Watanabe-Galloway S, Westman L, et al. Temporal and geospatial trends of pediatric cancer incidence in Nebraska over a 24-year period. Cancer Epidemiol. Feb 2018;52:83-90. doi:10.1016/j.canep.2017.12.006
27. Weichenthal S, Lavigne E, Valois MF, et al. Spatial variations in ambient ultrafine particle concentrations and the risk of incident prostate cancer: A case-control study. Environ Res. Jul 2017;156:374-380. doi:10.1016/j.envres.2017.03.035
28. Mobley LR, Scott L, Rutherford Y, Kuo TM. Using residential segregation to predict colorectal cancer stage at diagnosis: two different approaches. Ann Epidemiol. Jan 2017;27(1):10-19. doi:10.1016/j.annepidem.2016.11.008
29. Shalowitz DI, Vinograd AM, Giuntoli RL, 2nd. Geographic access to gynecologic cancer care in the United States. Gynecol Oncol. Jul 2015;138(1):115-20. doi:10.1016/j.ygyno.2015.04.025
30. Najafabadi AT, Pourhassan M. Integrating the geographic information system into cancer research. Indian J Cancer. Jan-Mar 2011;48(1):105-109. doi:10.4103/0019-509x.75834
31. Siegel RL, Jemal A, Wender RC, Gansler T, Ma J, Brawley OW. An assessment of progress in cancer control. CA Cancer J Clin. Sep 2018;68(5):329-339. doi:10.3322/caac.21460
32. Cramb SM, Moraga P, Mengersen KL, Baade PD. Spatial variation in cancer incidence and survival over time across Queensland, Australia. Spat Spatiotemporal Epidemiol. Nov 2017;23:59-67. doi:10.1016/j.sste.2017.09.002
33. Sahar L, Foster SL, Sherman RL, et al. GIScience and cancer: State of the art and trends for cancer surveillance and epidemiology. Cancer. Aug 1 2019;125(15):2544-2560. doi:10.1002/cncr.32052
34. Koch T. Cartographies of disease : maps, mapping, and medicine. 1st ed. ESRI Press; 2005:xvii, 389 p.
35. Gammon MD, Neugut AI, Santella RM, et al. The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat. Jun 2002;74(3):235-54. doi:10.1023/a:1016387020854
36. Clarke CA, Glaser SL, West DW, et al. Breast cancer incidence and mortality trends in an affluent population: Marin County, California, USA, 1990-1999. Breast Cancer Res. 2002;4(6):R13. doi:10.1186/bcr458
37. Bove FJ, Ruckart PZ, Maslia M, Larson TC. Mortality study of civilian employees exposed to contaminated drinking water at USMC Base Camp Lejeune: a retrospective cohort study. Environ Health. Aug 13 2014;13:68. doi:10.1186/1476-069X-13-68
38. Bove FJ, Ruckart PZ, Maslia M, Larson TC. Evaluation of mortality among marines and navy personnel exposed to contaminated drinking water at USMC base Camp Lejeune: a retrospective cohort study. Environ Health. Feb 19 2014;13(1):10. doi:10.1186/1476-069X-13-10
39. Ruckart PZ, Bove FJ, Maslia M. Evaluation of exposure to contaminated drinking water and specific birth defects and childhood cancers at Marine Corps Base Camp Lejeune, North Carolina: a case-control study. Environ Health. Dec 4 2013;12:104. doi:10.1186/1476-069X-12-104
40. Antao VC, Larson TC, Horton DK. Libby vermiculite exposure and risk of developing asbestos-related lung and pleural diseases. Curr Opin Pulm Med. Mar 2012;18(2):161-7. doi:10.1097/MCP.0b013e32834e897d
41. McDonald JC, McDonald AD, Armstrong B, Sebastien P. Cohort study of mortality of vermiculite miners exposed to tremolite. Br J Ind Med. Jul 1986;43(7):436-44. doi:10.1136/oem.43.7.436
42. Krieger N, Zierler S, Hogan JW, et al. Geocoding and measurement of neighborhood socioeconomic position: a US perspective. Neighborhoods and health. 2003:147-178.
43. Schiewe J. Empirical studies on the visual perception of spatial patterns in choropleth maps. KN-Journal of Cartography and Geographic Information. 2019;69(3):217-228.
44. Richards TB, Berkowitz Z, Thomas CC, et al. Choropleth map design for cancer incidence, part 2. Prev Chronic Dis. Jan 2010;7(1):A24.
45. Kennedy S. The small number problem and the accuracy of spatial databases. Accuracy of spatial databases. 1989:187-196.
46. Brewer CA, Pickle L. Evaluation of methods for classifying epidemiological data on choropleth maps in series. Ann Assoc Am Geogr. 2002;92(4):662-681.
47. Cromley RG, Ye Y. Ogive-based legends for choropleth mapping. Cartography and Geographic Information Science. 2006;33(4):257-268.
48. Richards TB, Berkowitz Z, Thomas CC, et al. Choropleth map design for cancer incidence, part 1. Prev Chronic Dis. Jan 2010;7(1):A23.
49. Krieger N, Waterman P, Chen JT, Soobader M-J, Subramanian SV, Carson R. Zip code caveat: bias due to spatiotemporal mismatches between zip codes and us census–defined geographic areas—the public health disparities geocoding project. American journal of public health. 2002;92(7):1100-1102.
50. Grubesic TH, Matisziw TC. On the use of ZIP codes and ZIP code tabulation areas (ZCTAs) for the spatial analysis of epidemiological data. Int J Health Geogr. Dec 13 2006;5:58. doi:10.1186/1476-072X-5-58
51. Zhu L, Waller LA, Ma J. Spatial-temporal disease mapping of illicit drug abuse or dependence in the presence of misaligned ZIP codes. GeoJournal. Jun 1 2013;78(3):463-474. doi:10.1007/s10708-011-9429-3
52. Golden R, Schell JD. Using ZIP code and GIS studies to assess disease risk. Environ Health Perspect. Jan 2008;116(1):A18; author reply A18-9. doi:10.1289/ehp.10840
53. Grubesic TH, Matisziw TC. On the use of ZIP codes and ZIP code tabulation areas (ZCTAs) for the spatial analysis of epidemiological data. International journal of health geographics. 2006;5(1):1-15.
54. Rushton G, Armstrong MP, Gittler J, et al. Geocoding health data: the use of geographic codes in cancer prevention and control, research and practice. CRC Press; 2007.
55. Bureau USC. ZIP Code Tabulation Areas (ZCTAs). United State Census Bureau,. Updated August 26, 2020. Accessed January 22, 2021, 2021. https://www.census.gov/programs-surveys/geography/guidance/geo-areas/zctas.html
56. Beyer KM, Rushton G. Mapping cancer for community engagement. Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S. Prev Chronic Dis. Jan 2009;6(1):A03.
57. ESRI. ESIR. Accessed 11/2/2020, 2020. https://www.esri.com/arcgis-blog/products/product/mapping/about-the-geometrical-interval-classification-method/
58. ESRI. How Hot Spot Analysis (Getis-Ord Gi*) works. ESRI. Accessed January 22, 2021, 2021. https://desktop.arcgis.com/en/arcmap/10.3/tools/spatial-statistics-toolbox/h-how-hot-spot-analysis-getis-ord-gi-spatial-stati.htm
59. Gunarathna M, Kumari M, Nirmanee K. Evaluation of interpolation methods for mapping pH of groundwater. International journal of latest technology in engineering, management & applied science. 2016;3:1-5.
60. Duong Q, Hill CL, Jr., Janitz AE, Campbell JE. Trends in Lung and Bronchus, Prostate, Female Breast, and Colon and Rectum Cancers Incidence and Mortality in Oklahoma and the United States from 1999 to 2012. J Okla State Med Assoc. Jul-Aug 2016;109(7-8):347-353.
61. Rushton G. Public health, GIS, and spatial analytic tools. Annu Rev Publ Health. 2003;24:43-56. doi:10.1146/annurev.publhealth.24.012902.140843
62. Talbot TO, Kulldorff M, Forand SP, Haley VB. Evaluation of spatial filters to create smoothed maps of health data. Stat Med. Sep 15-30 2000;19(17-18):2399-408. doi:10.1002/1097-0258(20000915/30)19:17/18<2399::aid-sim577>3.0.co;2-r